MedPath

A Study to Investigate the Effects of Heated Humidification During Non-Invasive Ventilation

Not Applicable
Completed
Conditions
Obesity Hypoventilation Syndrome
Chronic Obstructive Pulmonary Disease
Neuromuscular Disease
Chronic Respiratory Hypercapnic Failure
Interventions
Device: non-invasive ventilation heated humidification (Fisher-Paykel MR810 and MR850 humidifiers)
Registration Number
NCT01372072
Lead Sponsor
Guy's and St Thomas' NHS Foundation Trust
Brief Summary

Noninvasive ventilation (NIV) is a form of ventilation delivered by a mask and is an important mode of treatment in patients with both acute and chronic respiratory (breathing) failure. Humidification is widely accepted as an essential part of the ventilation strategy in patients receiving invasive ventilation (i.e. via a tube inserted into the mouth), but its role during NIV use is not proven. Consequently, there is a variation in practice with regard to humidification during NIV. Humidification is important in maintaining upper and lower airway mucosal function and patients requiring NIV often report symptoms, such as throat dryness, due to a lack of airway humidity. Success of NIV in the acute setting is dependent on many factors including, patient tolerance of NIV during the acute phase. In patients with chronic obstructive airways disease (COPD), poor tolerance results in NIV failure, which necessitates endotracheal intubation or treatment failure. Furthermore, invasive ventilation increases the risk of a hospital acquired pneumonia, which is associated with a worse outcome. In the long term setting of NIV use, again patients frequently report symptoms due to drying of the airways and adherence to NIV can be highly variable. Adherence in these patients is important in improving both quality and length of life. Humidification devices may be technically effective, but clinicians have concerns regarding potential negative effects of these devices. There is a requirement to evaluate the use of humidification in both the acute and long term use of NIV, particular, in terms of patient ventilator interaction, which will impact on comfort and adherence to NIV. This will effect the overall effectiveness of ventilation. The investigators propose a randomised controlled trial to investigate the effects of a humidification system during noninvasive ventilation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • hypercapnic respiratory failure
  • age > 18
  • requiring non-invasive ventilation
Exclusion Criteria
  • psychiatric illness
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Humidificationnon-invasive ventilation heated humidification (Fisher-Paykel MR810 and MR850 humidifiers)Patients in this arm of the trial will receive humidification with the non-invasive ventilation.
Primary Outcome Measures
NameTimeMethod
Adherence to NIVup to 8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St Thomas' Hospital

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath